Turinabol

Turinabol is an anabolic steroid that was first developed in the 1960s by the East German pharmaceutical company Jenapharm. It is a derivative of dianabol, but it does not aromatize into estrogen. This makes it a popular choice among athletes and bodybuilders who want to avoid the water retention and gynecomastia that can come with other steroids.

History

Turinabol was first synthesized in 1962 by the East German pharmaceutical company Jenapharm. It was developed as a means to build lean muscle mass in athletes, and was widely used by East German athletes during the Cold War. The use of Turinabol and other anabolic steroids was part of a state-sponsored program to enhance the performance of East German athletes in international competitions.

Pharmacology

Turinabol is a derivative of dianabol, but unlike its parent compound, it does not aromatize into estrogen. This means that it does not cause the same side effects as other anabolic steroids, such as water retention and gynecomastia. Instead, Turinabol promotes lean muscle growth, making it a popular choice among bodybuilders and athletes.

Side Effects

Despite its benefits, Turinabol is not without its risks. Long-term use can lead to liver damage, cardiovascular disease, and in some cases, death. It can also cause virilization in women, leading to characteristics such as facial hair growth and a deepened voice.

Legal Status

In many countries, including the United States, Turinabol is classified as a controlled substance. This means that it is illegal to possess, distribute, or use the drug without a prescription. Despite this, it remains popular in the bodybuilding community and is often obtained through illegal means.

See Also

• Anabolic steroid
• Dianabol
• Estrogen
• Controlled substance